Jazz Pharmaceuticals Director Heather Ann McSharry Disposes Shares for Tax Obligations
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Alert: Jazz Pharmaceuticals plc (NASDAQ: JAZZ)
**Insider:** McSharry Heather Ann (Director)
**Filing Date:** September 02, 2026
**Transaction Date:** August 31, 2026
### Transaction Summary
* **Action:** Disposition (Tax Withholding / Code F)
* **Security:** Ordinary Shares
* **Shares Transacted:** 1,855
* **Average Price:** ~$241.42
* **Total Value:** $447,827.27
* **Shares Remaining:** 18,199
*Note: Shares were sold/withheld to satisfy tax liabilities from RSU vesting.*
Comprehensive Analysis
Executive Summary
On September 2, 2026, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) reported a Form 4 transaction executed by Director Heather Ann McSharry. On August 31, 2026, McSharry disposed of an aggregate of 1,855 Ordinary Shares at an average weighted price of approximately $241.42 per share, representing a total transaction value of $447,827.27.
Transaction Breakdown
- Transaction 1: 15 shares disposed at $244.6447 per share.
- Transaction 2: 1,840 shares disposed at $241.39 per share.
- Transaction Code:
F(Payment of exercise price or tax liability by delivering or withholding securities). - Footnote Context: The shares were sold/withheld exclusively to satisfy statutory tax obligations associated with the vesting of previously granted restricted stock units (RSUs).
Ownership Post-Transaction
Following the transactions, Director McSharry directly holds 18,199 Ordinary Shares in Jazz Pharmaceuticals plc.
Market & Trading Significance
This disposition is categorized as Low Trading Significance because it reflects a standard, nondiscretionary tax withholding event (Transaction Code F) tied to equity compensation vesting, rather than an open-market discretionary sale.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.